dapagliflozin
astrazeneca
['dapagliflozin', 'cardio']
#esccongress | dapa-hf and deliver
dapagliflozin reduced the risk of cardiovascular death, all cause death, total hf hospitalisations and cardiovascular death heart attack and stroke in all patients regardless of their ef. 
Latest research in cardiology | Breaking news, insights, interviews, live tweeting and updates from major conferences. Co-published by @ilpensiero | @think2it